These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2890443)

  • 1. Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
    Mayer RD; Lee KE; Cockett AT
    Cancer Chemother Pharmacol; 1987; 20(3):207-10. PubMed ID: 2890443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved use of buthionine sulfoximine to prevent cisplatin nephrotoxicity in rats.
    Mayer RD; Lee KE; Cockett AT
    J Cancer Res Clin Oncol; 1989; 115(5):418-22. PubMed ID: 2808478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of systemic glutathione depletion by buthionine sulfoximine on sensitivity of murine bladder cancer to cytotoxic agents.
    Lee KE; Mayer RD; Cockett AT
    Urology; 1989 Dec; 34(6):376-80. PubMed ID: 2595883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of buthionine sulfoximine on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Fischer 344 rats.
    Rankin GO; Teets VJ; Nicoll DW; Brown PI
    Toxicol Lett; 1990 Jun; 52(1):91-100. PubMed ID: 2356574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against cisplatin toxicity by administration of glutathione ester.
    Anderson ME; Naganuma A; Meister A
    FASEB J; 1990 Nov; 4(14):3251-5. PubMed ID: 2227215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glutathione for cisplatin nephrotoxicity in young and adult rats.
    Appenroth D; Winnefeld K
    Ren Fail; 1993; 15(2):135-9. PubMed ID: 8469780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis.
    Yokomizo A; Kohno K; Wada M; Ono M; Morrow CS; Cowan KH; Kuwano M
    J Biol Chem; 1995 Aug; 270(33):19451-7. PubMed ID: 7642628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
    Kera Y; Ohbora Y; Komura S
    Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gamma-glutamyl cycle and glutathione levels in rat mammary gland explants.
    Puente J; Devoto MA; Sapag-Hagar M
    Int J Tissue React; 1986; 8(2):105-10. PubMed ID: 2870991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between thiol depletion and chemosensitization in a transplantable murine bladder tumor.
    Tomashefsky P; Astor M; White RD
    J Natl Cancer Inst; 1985 Jun; 74(6):1233-8. PubMed ID: 3858595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous inhibition of renal phospholipase A(2) and glutathione synthesis by manoalide and DL-buthionine sulfoximine induces acute tubular dysfunction in rats.
    Soejima A; Ishizuka S; Miyake N; Fukuoka K; Suzuki M; Kamiya Y; Nagasawa T
    Exp Nephrol; 2000; 8(2):84-90. PubMed ID: 10729747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of rat UDP-glucuronosyltransferase and glutathione S-transferase activities by L-buthionine-S,R-sulfoximine without induction of cytochrome P-450.
    Manning BW; Franklin MR
    Toxicology; 1990 Dec; 65(1-2):149-59. PubMed ID: 2125759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Ito K; Nomura H; Nakanishi K
    Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of buthionine sulphoximine, glutathione and methimazole on the renal disposition of cisplatin and on cisplatin-induced nephrotoxicity in rats: pharmacokinetic-toxicodynamic analysis.
    Hanada K; Mukasa Y; Nomizo Y; Ogata H
    J Pharm Pharmacol; 2000 Dec; 52(12):1483-90. PubMed ID: 11197076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
    Campbell EB; Hayward ML; Griffith OW
    Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.